Parent Page: Directory id: 22535 Active Page: Detailsid:23325



Bradley C Gehrs, MD

Bradley C. Gehrs, MD

Interim Director of Transfusion Services

Assistant Professor of Pathology

Staff Pathologist, OU Medical Center

The University of Oklahoma Health Sciences Center
Children's Hospital
1200 N. Everett Dr 
Oklahoma City, OK 73104


Academic Section(s):



  • Valparaiso University
    Valparaiso, Indiana
    B.S. in Chemistry, Biology, and Mathematics, 1989
  • University of North Carolina
    Chapel Hill, North Carolina
    Doctoral Student, Curriculum in Toxicology (1989 - 1990 & 1992 - 1995) 
    M.D., 1997

Select Publications:

  1. Gehrs BC, Riddle MM, Williams WC, Smialowicz RJ. Alterations in the developing immune system of the F344 rat after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. II. Effects on the pup and the adult. Toxicology. 1997 Oct 19;122(3):229-40.

  2. Gehrs BC, Smialowicz RJ. Persistent suppression of the delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.Toxicology. 1999 May 3;134(1):79-88.

  3. Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol. 2002 Apr;69(4):258-71.

  4. Liu Z, Guo BL, Gehrs BC, Nan L, Lopez RD. Ex vivo expanded human Vγ9Vδ2+ γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro. J Urol. 2005 May;173(5):1552-6.

  5. Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa T, Gehrs B, Rosenthal E, Chen D, Shackley B, Harris KW, Selander KS: Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res. 2006 Jul;4(7):437-47.

  6. Merrell MA, Wakchoure S, Ilvesaro JM, Zinn K, Gehrs B, Lehenkari PP, Harris KW, Selander KS. Differential effects of Ca2+ on bisphosphonate-induced growth inhibition in breast cancer and mesothelioma cells. Eur J Pharmacol. 2007 Mar 15;559(1):21-31.

  7. Beavers C, Harrison M, Gehrs B, Blick KE, Lethargy and seizures in a 52-year-old male, Lab Med, July 2009; 40(7);405-407.

  8. Rapisarda A, Hollingshead M, Uranchimeg B, Bonomi CA, Borgel SD, Carter JP, Gehrs B, Raffeld M, Kinders RJ, Parchment R, Anver MR, Shoemaker RH, Milillo G. Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition. Mol Cancer Ther July 2009;8(7):1867-1877.

  9. Al-Kali A, Cherry M, Kimmel K, Holter J, Kern W, Gehrs B, Ozer H, Selby G. A case of acute myeloid leukemia initially treated as chronic lymphocytic leukemia: what do we know about t(4;12)(q12;p13)? [Letter to the Editor] Cancer Genet Cytogenet Dec 2010;203(2):348-51.

  10. Fung KM, Chakrabarty JH, Kern WF, Magharyous H, Gehrs BC, Li S. Case Report: Intravascular large B-cell lymphoma with hemophagocytic syndrome (Asian variant) in a Caucasian patient. Int J Clin Exp Pathol 2012;5(5):448-454. (Online only journal)